2008
DOI: 10.1016/j.canlet.2008.02.025
|View full text |Cite
|
Sign up to set email alerts
|

Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
39
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(43 citation statements)
references
References 26 publications
4
39
0
Order By: Relevance
“…As per available report, it is suggested that galangin suppresses the b-catenin regulated transcription in case of liver cancers (JungSug et al 2011). Galangin disrupts cell division of cancer cells at the G 0 -G 1 phase of cell cycle and it is also a strong inhibitor of Hs578T cell proliferation (Tolomeo et al 2008). Our results revealed that galangin demonstrated maximum antineoplastic effects against Sarcoma 180 and are in agreement with earlier reported results (Murray et al 2006).…”
Section: Discussionsupporting
confidence: 93%
“…As per available report, it is suggested that galangin suppresses the b-catenin regulated transcription in case of liver cancers (JungSug et al 2011). Galangin disrupts cell division of cancer cells at the G 0 -G 1 phase of cell cycle and it is also a strong inhibitor of Hs578T cell proliferation (Tolomeo et al 2008). Our results revealed that galangin demonstrated maximum antineoplastic effects against Sarcoma 180 and are in agreement with earlier reported results (Murray et al 2006).…”
Section: Discussionsupporting
confidence: 93%
“…Other studies also reported galangin’s ability to suppress cell proliferation and induce apoptosis in several other cancer cell lines [2,7,8]. These observations strongly suggest that galangin is a potential antitumor agent.…”
Section: Discussionsupporting
confidence: 52%
“…A large variety of chemotherapeutic agents induce apoptosis in susceptible cell lines [19][20][21][22]. The cell line studied here, K562, is an erythroleukemia cell line; immunoblotting and various activity assays showed that caspase 3, an enzyme that cleaves full length poly (ADP-ribose) polymerase (PARP), is activated in several human leukemia lines treated with apoptosis inducing agents [23].…”
Section: Introductionmentioning
confidence: 99%